112P Pseudoprogression predicts better prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors


Senturk Oztas N., Alkan G., Degerli E., Turna Z. H., Ozguroglu M.

Immuno-Oncology and Technology, cilt.16, ss.1, 2022 (Düzenli olarak gerçekleştirilen hakemli kongrenin bildiri kitabı)